| An international consensus approach to the management of atypical hemolytic uremic syndrome in children C Loirat, F Fakhouri, G Ariceta, N Besbas, M Bitzan, A Bjerre, R Coppo, ... Pediatric nephrology 31, 15-39, 2016 | 662 | 2016 |
| Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections H Karch, M Bielaszewska, M Bitzan, H Schmidt Diagnostic microbiology and infectious disease 34 (3), 229-243, 1999 | 313 | 1999 |
| Non-enteropathic hemolytic uremic syndrome: causes and short-term course AR Constantinescu, M Bitzan, LS Weiss, E Christen, BS Kaplan, A Cnaan, ... American Journal of Kidney Diseases 43 (6), 976-982, 2004 | 297 | 2004 |
| Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome F Gunzer, H Böhm, H Rüssmann, M Bitzan, S Aleksic, H Karch Journal of Clinical microbiology 30 (7), 1807-1810, 1992 | 295 | 1992 |
| The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a Central European, multicentre study M Bitzan, K Ludwig, M Klemt, H König, J Büren, DE Müller-Wiefel Epidemiology & Infection 110 (2), 183-196, 1993 | 190 | 1993 |
| High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome M Bitzan, E Moebius, K Ludwig, DE Müller-Wiefel, J Heesemann, H Karch The Journal of pediatrics 119 (3), 380-385, 1991 | 178 | 1991 |
| Molecular Characteristics and Epidemiological Significance of Shiga Toxin-Producing Escherichia coliO26 Strains WL Zhang, M Bielaszewska, A Liesegang, H Tschäpe, H Schmidt, ... Journal of Clinical Microbiology 38 (6), 2134-2140, 2000 | 159 | 2000 |
| Management of hemolytic uremic syndrome C Loirat, J Saland, M Bitzan La Presse Médicale 41 (3), e115-e135, 2012 | 139 | 2012 |
| Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro M Bitzan, S Richardson, C Huang, B Boyd, M Petric, MA Karmali Infection and immunity 62 (8), 3337-3347, 1994 | 132 | 1994 |
| Treatment options for HUS secondary to Escherichia coli O157: H7 M Bitzan Kidney International 75, S62-S66, 2009 | 129 | 2009 |
| An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome S Johnson, J Stojanovic, G Ariceta, M Bitzan, N Besbas, M Frieling, ... Pediatric nephrology 29, 1967-1978, 2014 | 125 | 2014 |
| ARHGDIA: a novel gene implicated in nephrotic syndrome IR Gupta, C Baldwin, D Auguste, KCH Ha, J El Andalousi, S Fahiminiya, ... Journal of medical genetics 50 (5), 330-338, 2013 | 118 | 2013 |
| Spectrum of mutations in the renin–angiotensin system genes in autosomal recessive renal tubular dysgenesis O Gribouval, V Morinière, A Pawtowski, C Arrondel, SL Sallinen, ... Human mutation 33 (2), 316-326, 2012 | 109 | 2012 |
| Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. MM Bitzan, Y Wang, J Lin, PA Marsden The Journal of clinical investigation 101 (2), 372-382, 1998 | 104 | 1998 |
| Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy IM Hoffmann, BK Rubin, SS Iskandar, MS Schechter, SK Nagaraj, ... Pediatric pulmonology 34 (5), 375-377, 2002 | 100 | 2002 |
| Shiga Toxin-Producing Escherichia coli Infection and Antibodies against Stx2 and Stx1 in Household Contacts of Children with Enteropathic Hemolytic-Uremic … K Ludwig, V Sarkim, M Bitzan, MA Karmali, C Bobrowski, H Ruder, ... Journal of clinical microbiology 40 (5), 1773-1782, 2002 | 100 | 2002 |
| Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers M Bitzan, R Poole, M Mehran, E Sicard, C Brockus, C Thuning-Roberson, ... Antimicrobial Agents and Chemotherapy 53 (7), 3081-3087, 2009 | 99 | 2009 |
| Immune Response to Non-O157 Vero Toxin—Producing Escherichia coli in Patients with Hemolytic Uremic Syndrome K Ludwig, M Bitzan, S Zimmermann, M Kloth, H Ruder, DE Müller-Wiefel Journal of Infectious Diseases 174 (5), 1028-1039, 1996 | 87 | 1996 |
| Treatment of typical (enteropathic) hemolytic uremic syndrome M Bitzan, F Schaefer, D Reymond Seminars in thrombosis and hemostasis 36 (06), 594-610, 2010 | 86 | 2010 |
| Inhibition of Helicobacter pylori and Helicobacter mustelae Binding to Lipid Receptors by Bovine Colostrum MM Bitzan, BD Gold, DJ Philpott, M Huesca, PM Sherman, H Karch, ... Journal of Infectious Diseases 177 (4), 955-961, 1998 | 86 | 1998 |
